Discussion
The present study showed that (1) among patients treated with CA plus bepridil for persistent AF with severe LA enlargement, the duration of bepridil use did not affect the rate of recurrent AF after CA, and (2) the presence of LA reverse remodeling at 6 months of follow-up was an independent predictor of the recurrence of AF after CA.